Literature DB >> 35747541

Tackling Quality-It's Never a Level Playing Field: Companion Piece to the Neurology Outcome Measure Set.

Brian Cabaniss1, Korwyn Williams1, Meghan Ward1, Desiree Cremeen1, Kavita Nair1.   

Abstract

The American Academy of Neurology (AAN) has recently proposed 3 outcome metrics crafted to be both broadly applicable across neurologic diseases and to function as potential tools to facilitate quality improvement. These measures should be of interest to physicians and payers due to the increasing linkage of reimbursement to quality care. However, the use of quality measures cannot exist in a vacuum as external factors outside of physician control can negatively affect these metrics. The original Centers for Medicare and Medicaid (CMS) value-based programs illustrate the necessity for iterative review and revision of outcome metrics to allow for risk adjustment to avoid unjust penalties. Accordingly, at this time, the Neurology Outcome Measurement Set is not suitable for inclusion in a quality payment program.
© 2022 American Academy of Neurology.

Entities:  

Year:  2022        PMID: 35747541      PMCID: PMC9208426          DOI: 10.1212/CPJ.0000000000001153

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN: 2163-0402


  2 in total

1.  Quality improvement in neurology: Neurology Outcomes Quality Measurement Set.

Authors:  Jason J Sico; Aarti Sarwal; Sarah M Benish; Neil A Busis; Bruce H Cohen; Rohit R Das; Shari Finsilver; John J Halperin; Adam G Kelly; Lisa Meunier; Michael S Phipps; Parthasarathy D Thirumala; Raissa Villanueva; Jane von Gaudecker; Amy Bennett; Anant M Shenoy
Journal:  Neurology       Date:  2020-05-12       Impact factor: 9.910

2.  Impact of Race/Ethnicity and Socioeconomic Status on Risk-Adjusted Hospital Readmission Rates Following Hip and Knee Arthroplasty.

Authors:  Grant R Martsolf; Marguerite L Barrett; Audrey J Weiss; Ryan Kandrack; Raynard Washington; Claudia A Steiner; Ateev Mehrotra; Nelson F SooHoo; Rosanna Coffey
Journal:  J Bone Joint Surg Am       Date:  2016-08-17       Impact factor: 5.284

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.